Sien Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sien Zhang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Guiqing Liao
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China
6 shared publications Le Yang
Hospital of Stomatology, Sun Yat-sen University
4 shared publicationsMin Huang
Hospital of Stomatology, Sun Yat-sen University
4 shared publicationsPeiyao Li
Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University
4 shared publicationsJingxin Ma
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China
3 shared publicationsYujie Liang
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
Contralateral facial artery-based chimeric flap for reconstruction of large oral cavity defects in elderly pre-frail patients: a two-case report
Background: Large oral cavity defects after oncologic ablation require reliable reconstruction to restore oral function and aesthetics. Although free flap reconstruction remains a standard option, it may be unsuitable for elderly pre-frail patients with multiple comorbidities. This report describes a contralateral facial artery-based chimeric flap combining a nasolabial island flap and a submental artery island flap for reconstruction of large oral cavity defects. Case presentation: Two elderly pre-frail patients with squamous cell carcinoma of the tongue and floor of the mouth underwent wide local excision, resulting in moderately large soft-tissue defects involving the tongue and floor of the mouth. The defects could not be adequately reconstructed using either a nasolabial island flap or a submental artery island flap alone. A contralateral facial artery-based chimeric flap was therefore designed to provide sufficient local tissue volume while avoiding microvascular anastomosis. All donor-site incisions were closed primarily, and no immediate donor-site wound complications occurred. At approximately 1 year of follow-up, both patients demonstrated acceptable oral intake and overall functional recovery; however, mild cheek depression, persistent partial facial paralysis in Case 2, and intraoral hair growth in the male patient were observed. Conclusions: A contralateral facial artery-based chimeric flap composed of a nasolabial island flap and a submental artery island flap may be a useful reconstructive option for large oral cavity defects, particularly in elderly pre-frail patients who may be unsuitable candidates for free flap reconstruction.
- 1 September 2026
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
Open AccessContralateral facial artery-based chimeric flap for reconstruction of large oral cavity defects in elderly pre-frail patients: a two-case report
Background: Large oral cavity defects after oncologic ablation require reliable reconstruction to restore oral function and aesthetics. Although free flap reconstruction remains a standard option, it may be unsuitable for elderly pre-frail patients with multiple comorbidities. This report describes a contralateral facial artery-based chimeric flap combining a nasolabial island flap and a submental artery island flap for reconstruction of large oral cavity defects. Case presentation: Two elderly pre-frail patients with squamous cell carcinoma of the tongue and floor of the mouth underwent wide local excision, resulting in moderately large soft-tissue defects involving the tongue and floor of the mouth. The defects could not be adequately reconstructed using either a nasolabial island flap or a submental artery island flap alone. A contralateral facial artery-based chimeric flap was therefore designed to provide sufficient local tissue volume while avoiding microvascular anastomosis. All donor-site incisions were closed primarily, and no immediate donor-site wound complications occurred. At approximately 1 year of follow-up, both patients demonstrated acceptable oral intake and overall functional recovery; however, mild cheek depression, persistent partial facial paralysis in Case 2, and intraoral hair growth in the male patient were observed. Conclusions: A contralateral facial artery-based chimeric flap composed of a nasolabial island flap and a submental artery island flap may be a useful reconstructive option for large oral cavity defects, particularly in elderly pre-frail patients who may be unsuitable candidates for free flap reconstruction.
- Open Access
- 6 May 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (4) , 109601
Anatomical Predictors of Second Molar External Root Resorption: A Cone-Beam Computed Tomography Study of Impacted Third Molars
- 6 May 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (4) , 109601
Open AccessAnatomical Predictors of Second Molar External Root Resorption: A Cone-Beam Computed Tomography Study of Impacted Third Molars
- Open Access
- 7 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1760967
Clinical outcomes of the tunnelized-facial artery myomucosal island flaps in the oral cavity and comparison with cutaneous flaps in an animal model
Objective: This study aims to evaluate the clinical efficacy of tunnelized-facial artery myomucosal island flaps (t-FAMMIF) in reconstructing mucosal defects following oral cancer surgery and compare the characteristics between mucosal and cutaneous flaps. Methods: A total of 23 patients who underwent t-FAMMIF reconstruction were enrolled and monitored for functional recovery and complication resolution. Using propensity score matching, 20 cases were paired with a cohort of patients receiving cutaneous flaps (n=20 per group). Sensory function was assessed using the Semmes-Weinstein monofilament test and two-point discrimination tests, while motor function was evaluated with the Water Swallowing Test. Facial nerve function was assessed by House-Brackmann grading scale, wireless surface electromyography, and FaceGram software. Mouth opening was measured by maximum inter-incisal opening. Additionally, to explore the mechanisms underlying differential functional recovery, mucosal and cutaneous flaps were compared in a beagle dog model, with subsequent histological analysis. Results: Compared to the cutaneous flap group, the t-FAMMIF group exhibited superior aesthetic and sensory outcomes, with facial nerve dysfunction and trismus largely resolved by 6 months. Histological analysis in the animal model revealed that mucosal flaps preserved minor salivary glands and exhibited significantly reduced scar formation, providing a tissue-level explanation for the enhanced sensory recovery observed clinically. Conclusion: T-FAMMIF is an effective option for reconstructing small to moderate mucosal defects. Compared to cutaneous flaps, it provides advantages including superior aesthetic results, enhanced sensory recovery, minimized scarring, and preservation of salivary gland function.
- 7 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1760967
Open AccessClinical outcomes of the tunnelized-facial artery myomucosal island flaps in the oral cavity and comparison with cutaneous flaps in an animal model
Objective: This study aims to evaluate the clinical efficacy of tunnelized-facial artery myomucosal island flaps (t-FAMMIF) in reconstructing mucosal defects following oral cancer surgery and compare the characteristics between mucosal and cutaneous flaps. Methods: A total of 23 patients who underwent t-FAMMIF reconstruction were enrolled and monitored for functional recovery and complication resolution. Using propensity score matching, 20 cases were paired with a cohort of patients receiving cutaneous flaps (n=20 per group). Sensory function was assessed using the Semmes-Weinstein monofilament test and two-point discrimination tests, while motor function was evaluated with the Water Swallowing Test. Facial nerve function was assessed by House-Brackmann grading scale, wireless surface electromyography, and FaceGram software. Mouth opening was measured by maximum inter-incisal opening. Additionally, to explore the mechanisms underlying differential functional recovery, mucosal and cutaneous flaps were compared in a beagle dog model, with subsequent histological analysis. Results: Compared to the cutaneous flap group, the t-FAMMIF group exhibited superior aesthetic and sensory outcomes, with facial nerve dysfunction and trismus largely resolved by 6 months. Histological analysis in the animal model revealed that mucosal flaps preserved minor salivary glands and exhibited significantly reduced scar formation, providing a tissue-level explanation for the enhanced sensory recovery observed clinically. Conclusion: T-FAMMIF is an effective option for reconstructing small to moderate mucosal defects. Compared to cutaneous flaps, it provides advantages including superior aesthetic results, enhanced sensory recovery, minimized scarring, and preservation of salivary gland function.
- Open Access
- 27 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1755419
Immunotherapy-induced sialadenitis: sjögren’s syndrome or a new sialadenitis
Objective: Although immune checkpoint inhibitors (ICIs) have improved survival in head and neck squamous cell carcinoma (HNSCC), associated adverse events, such as sialadenitis, remain poorly characterized. This study aimed to define the clinicopathological features, establish the causal pathogenic mechanism, and validate a therapeutic target for ICI-associated sialadenitis. Methods: This study integrated three complementary approaches. First, a prospective cohort of 25 HNSCC patients underwent functional assessment of salivary and lacrimal glands before and after ICI therapy. Second, salivary gland tissues from separate cohorts of ICI-treated (n=30) and untreated control (n=30) patients were subjected to comprehensive analysis, including histology, multi-platform immunophenotyping (immunohistochemistry, multiplex immunofluorescence, flow cytometry), and cytokine quantification at both transcript and protein levels. Finally, a preclinical mouse model was established to confirm causality and validate the therapeutic efficacy of IL-17A blockade. Results: Following ICI treatment, patients showed significantly reduced salivary and lacrimal secretion ( P < 0.05). Histopathological analysis revealed extensive lymphocytic infiltration, marked periductal fibrosis, and substantial loss of acinar structures. The immune infiltrate was dominated by CD4 + T cells, particularly the Th17 subset, with corresponding upregulation of IL-17A both at transcriptional and protein levels. Crucially, we established a mouse model of anti-PD-1-induced sialadenitis and demonstrated that therapeutic blockade of IL-17A restores salivary function. Conclusion: This study establishes ICI-associated sialadenitis as a distinct pathological entity characterized by CD4 + T cell-driven inflammation mediated through the Th17/IL-17 axis, which differs from Sjögren syndrome, predominantly involving B cells and from IgG4 related sialadenitis. By demonstrating therapeutic efficacy in a preclinical model, our findings provide the first preclinical validation of the IL-17 axis as an actionable therapeutic target for this condition.
- 27 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1755419
Open AccessImmunotherapy-induced sialadenitis: sjögren’s syndrome or a new sialadenitis
Objective: Although immune checkpoint inhibitors (ICIs) have improved survival in head and neck squamous cell carcinoma (HNSCC), associated adverse events, such as sialadenitis, remain poorly characterized. This study aimed to define the clinicopathological features, establish the causal pathogenic mechanism, and validate a therapeutic target for ICI-associated sialadenitis. Methods: This study integrated three complementary approaches. First, a prospective cohort of 25 HNSCC patients underwent functional assessment of salivary and lacrimal glands before and after ICI therapy. Second, salivary gland tissues from separate cohorts of ICI-treated (n=30) and untreated control (n=30) patients were subjected to comprehensive analysis, including histology, multi-platform immunophenotyping (immunohistochemistry, multiplex immunofluorescence, flow cytometry), and cytokine quantification at both transcript and protein levels. Finally, a preclinical mouse model was established to confirm causality and validate the therapeutic efficacy of IL-17A blockade. Results: Following ICI treatment, patients showed significantly reduced salivary and lacrimal secretion ( P < 0.05). Histopathological analysis revealed extensive lymphocytic infiltration, marked periductal fibrosis, and substantial loss of acinar structures. The immune infiltrate was dominated by CD4 + T cells, particularly the Th17 subset, with corresponding upregulation of IL-17A both at transcriptional and protein levels. Crucially, we established a mouse model of anti-PD-1-induced sialadenitis and demonstrated that therapeutic blockade of IL-17A restores salivary function. Conclusion: This study establishes ICI-associated sialadenitis as a distinct pathological entity characterized by CD4 + T cell-driven inflammation mediated through the Th17/IL-17 axis, which differs from Sjögren syndrome, predominantly involving B cells and from IgG4 related sialadenitis. By demonstrating therapeutic efficacy in a preclinical model, our findings provide the first preclinical validation of the IL-17 axis as an actionable therapeutic target for this condition.
- Open Access
- 30 January 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (2) , e70604
Comprehensive tumour‐immune profiling reveals TREM2 + tumour‐associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma
Background: Lymph node (LN) metastasis is a well‐established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation of suppressive tumour immune microenvironment (TIME) is a major contributor to tumour immune evasion and metastasis. However, the TIME landscape underlying LN‐metastatic HNSCC remains poorly elucidated. Methods: A total of 688 866 single‐cell transcriptomes across 212 HNSCC samples were integrated. Comprehensive bioinformatic analyses on single‐cell RNA sequencing and microarray datasets revealed a TREM2 + tumour‐associated macrophage (TAM) cluster associated with LN metastasis. The functional role of TREM2 + TAMs was investigated through multiplex immunohistochemistry (mIHC) staining in clinical HNSCC cohort and in vitro co‐culture experiments. Furthermore, machine learning algorithms were employed to construct a prognostic model for HNSCC. Results: Integrative single‐cell analysis revealed the immunosuppressive TIME of LN‐metastatic HNSCC, characterised by high infiltration of exhausted CD8 + T cells (CD8 + Tex). We identified a specific TREM2 + TAM cluster that was strongly associated with CD8 + Tex infiltration and LN metastasis. In vitro experiment confirmed that TREM2 + TAMs promoted CD8 + T cell exhaustion. Mechanistically, TREM2 + TAMs exhibited a terminally differentiated phenotype driven by ETV5, and secreted SPP1 to interact with CD44 on CD8 + T cells, thus upregulating BHLHE40 to promote CD8 + Tex formation. Clinically, a prognostic model based on TREM2 + TAM signature genes was trained to independently predict HNSCC outcomes. Conclusions: This study delineates the mechanism that TREM2 + TAMs promote LN metastasis in HNSCC by facilitating CD8 + T cells exhaustion via SPP1–CD44–BHLHE40 axis, proposing TREM2 + TAMs as potential therapeutic target for HNSCC.
- 30 January 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (2) , e70604
Open AccessComprehensive tumour‐immune profiling reveals TREM2 + tumour‐associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma
Background: Lymph node (LN) metastasis is a well‐established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation of suppressive tumour immune microenvironment (TIME) is a major contributor to tumour immune evasion and metastasis. However, the TIME landscape underlying LN‐metastatic HNSCC remains poorly elucidated. Methods: A total of 688 866 single‐cell transcriptomes across 212 HNSCC samples were integrated. Comprehensive bioinformatic analyses on single‐cell RNA sequencing and microarray datasets revealed a TREM2 + tumour‐associated macrophage (TAM) cluster associated with LN metastasis. The functional role of TREM2 + TAMs was investigated through multiplex immunohistochemistry (mIHC) staining in clinical HNSCC cohort and in vitro co‐culture experiments. Furthermore, machine learning algorithms were employed to construct a prognostic model for HNSCC. Results: Integrative single‐cell analysis revealed the immunosuppressive TIME of LN‐metastatic HNSCC, characterised by high infiltration of exhausted CD8 + T cells (CD8 + Tex). We identified a specific TREM2 + TAM cluster that was strongly associated with CD8 + Tex infiltration and LN metastasis. In vitro experiment confirmed that TREM2 + TAMs promoted CD8 + T cell exhaustion. Mechanistically, TREM2 + TAMs exhibited a terminally differentiated phenotype driven by ETV5, and secreted SPP1 to interact with CD44 on CD8 + T cells, thus upregulating BHLHE40 to promote CD8 + Tex formation. Clinically, a prognostic model based on TREM2 + TAM signature genes was trained to independently predict HNSCC outcomes. Conclusions: This study delineates the mechanism that TREM2 + TAMs promote LN metastasis in HNSCC by facilitating CD8 + T cells exhaustion via SPP1–CD44–BHLHE40 axis, proposing TREM2 + TAMs as potential therapeutic target for HNSCC.
- Open Access
- 4 June 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1393687
Contralateral facial artery myomucosal island flap for the reconstruction of T2-T3 oncologic oral defects
Objectives: To avoid the oncologic risks of ipsilateral regional flaps, this study aimed to explore the feasibility and clinical outcomes of the contralateral-based facial artery myomucosal island flap (C-FAMMIF) for oral T2–T3 oncologic defects reconstruction.Methods: A study of flap anatomy was conducted on 7 cadaver samples and a cohort of 24 patients who received C-FAMMIF reconstruction after malignancy resection were retrospectively researched. A balanced anterolateral thigh flap (ALT) group of 47 patients was extracted as control group using propensity score matching method. Progression-free survival (PFS), functional outcomes, and donor site complications were assessed.Results: Consistent blood supply and drainage through facial artery and vein with median maximum pedicle length of 106 mm supported contralateral reconstruction. The superficial vein drainage pattern indicated safer flap harvest at contralateral neck under circumstances of ipsilateral neck dissections. The pedicle and marginal facial nerve formed three anatomical patterns. The surgical management of each was described. Patients with ipsilateral pN+ neck accounted for 41.7% and 40.4% in the C-FAMMIF and ALT group, respectively. The 2-year PFS rate between the C-FAMMIF and ALT groups was not significantly different (88.2% in C-FAMMIF group and 84.6% in ALT group, respectively, p = 0.6358). Promising recoveries were observed for swallowing function and tactile sensation. The donor sites healed upon primary closure without trismus or permanent facial palsy.Conclusion: Our findings suggested that C-FAMMIF is feasible and safe for T2-T3 oral oncologic defect reconstruction in patients with ipsilateral cN+ neck.
- 4 June 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1393687
Open AccessContralateral facial artery myomucosal island flap for the reconstruction of T2-T3 oncologic oral defects
Objectives: To avoid the oncologic risks of ipsilateral regional flaps, this study aimed to explore the feasibility and clinical outcomes of the contralateral-based facial artery myomucosal island flap (C-FAMMIF) for oral T2–T3 oncologic defects reconstruction.Methods: A study of flap anatomy was conducted on 7 cadaver samples and a cohort of 24 patients who received C-FAMMIF reconstruction after malignancy resection were retrospectively researched. A balanced anterolateral thigh flap (ALT) group of 47 patients was extracted as control group using propensity score matching method. Progression-free survival (PFS), functional outcomes, and donor site complications were assessed.Results: Consistent blood supply and drainage through facial artery and vein with median maximum pedicle length of 106 mm supported contralateral reconstruction. The superficial vein drainage pattern indicated safer flap harvest at contralateral neck under circumstances of ipsilateral neck dissections. The pedicle and marginal facial nerve formed three anatomical patterns. The surgical management of each was described. Patients with ipsilateral pN+ neck accounted for 41.7% and 40.4% in the C-FAMMIF and ALT group, respectively. The 2-year PFS rate between the C-FAMMIF and ALT groups was not significantly different (88.2% in C-FAMMIF group and 84.6% in ALT group, respectively, p = 0.6358). Promising recoveries were observed for swallowing function and tactile sensation. The donor sites healed upon primary closure without trismus or permanent facial palsy.Conclusion: Our findings suggested that C-FAMMIF is feasible and safe for T2-T3 oral oncologic defect reconstruction in patients with ipsilateral cN+ neck.
- Open Access
- 30 March 2024
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 125 (3) , 101861
Functional and esthetic reconstruction of composite lower lip defects with a motor-innervated chimeric facial artery buccinator myomucosal-submental island flap
- 30 March 2024
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 125 (3) , 101861
Open AccessFunctional and esthetic reconstruction of composite lower lip defects with a motor-innervated chimeric facial artery buccinator myomucosal-submental island flap
- 7 August 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 169, 256-272
Injectable decellularized extracellular matrix hydrogel promotes salivary gland regeneration via endogenous stem cell recruitment and suppression of fibrogenesis
- 7 August 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 169, 256-272
Injectable decellularized extracellular matrix hydrogel promotes salivary gland regeneration via endogenous stem cell recruitment and suppression of fibrogenesis
- Open Access
- 14 June 2023
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 27 (8) , 4747-4755
The contralateral-based submental artery island flap: feasibility and oncological safety in oral cancer–related defect reconstruction
Objectives: Oncologic risk is a serious concern of submental artery island flaps. Here, we introduce the contralateral-based submental artery island flap (C-SAIF) and demonstrate its feasibility and long-term oncological safety in reconstructing oral cancer–related defects. Methods: An anatomical study was performed concentrating on the pedicle length in seven cadavers. Then, a retrospective study was carried out on C-SAIF patients operated on by a single team. The standard surgical technique of C-SAIF was conducted. Outcomes including operative time, length of hospital stay, volume of intraoperative blood loss, and scores of the Multidisciplinary Salivary Gland Society (MSGS) questionnaire were compared with a similar cohort reconstructed with anterolateral thigh free flap (ALTF). In addition, oncological outcomes were evaluated by the 5-year cumulative survival rate between C-SAIF and ALTF patients. Results: The pedicle length of C-SAIF was sufficient for the flap to be extended to the contralateral oral cavity. Fifty-two patients were included in the retrospective study, and nineteen of them underwent reconstruction with C-SAIF. The operative time of C-SAIF was shorter (p = 0.003), and the intraoperative blood loss was less (p = 0.004) than that of ALTF. There was no difference in MSGS scores. The results of survival analysis revealed comparable survival curves for the two groups in terms of overall survival, disease-specific survival, and disease-free survival. Conclusion: C-SAIF is a feasible and reliable flap for reconstructing oral cancer–related defects. Moreover, it is an effective island flap to preserve the perforator and pedicle without compromising oncological safety.
- 14 June 2023
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 27 (8) , 4747-4755
Open AccessThe contralateral-based submental artery island flap: feasibility and oncological safety in oral cancer–related defect reconstruction
Objectives: Oncologic risk is a serious concern of submental artery island flaps. Here, we introduce the contralateral-based submental artery island flap (C-SAIF) and demonstrate its feasibility and long-term oncological safety in reconstructing oral cancer–related defects. Methods: An anatomical study was performed concentrating on the pedicle length in seven cadavers. Then, a retrospective study was carried out on C-SAIF patients operated on by a single team. The standard surgical technique of C-SAIF was conducted. Outcomes including operative time, length of hospital stay, volume of intraoperative blood loss, and scores of the Multidisciplinary Salivary Gland Society (MSGS) questionnaire were compared with a similar cohort reconstructed with anterolateral thigh free flap (ALTF). In addition, oncological outcomes were evaluated by the 5-year cumulative survival rate between C-SAIF and ALTF patients. Results: The pedicle length of C-SAIF was sufficient for the flap to be extended to the contralateral oral cavity. Fifty-two patients were included in the retrospective study, and nineteen of them underwent reconstruction with C-SAIF. The operative time of C-SAIF was shorter (p = 0.003), and the intraoperative blood loss was less (p = 0.004) than that of ALTF. There was no difference in MSGS scores. The results of survival analysis revealed comparable survival curves for the two groups in terms of overall survival, disease-specific survival, and disease-free survival. Conclusion: C-SAIF is a feasible and reliable flap for reconstructing oral cancer–related defects. Moreover, it is an effective island flap to preserve the perforator and pedicle without compromising oncological safety.